Zylox-Tonbridge Medical Technology Co., Ltd. (2190.HK)
HKD 11.12
(0.18%)
HKD 11.12
(0.18%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 527.75 Million | 334.09 Million | 177.91 Million | 27.63 Million | 4.91 Million |
| Cost of Revenue | 142.76 Million | 81.42 Million | 46.03 Million | 11.34 Million | 3.72 Million |
| Gross Profit | 384.98 Million | 252.66 Million | 131.88 Million | 16.28 Million | 1.19 Million |
| Operating Expenses | 541.51 Million | 474.85 Million | 349.93 Million | 114.07 Million | 70.13 Million |
| Selling, General and Administrative Expenses | 277.91 Million | 249.47 Million | 195.86 Million | 51.44 Million | 23.72 Million |
| Research and Development Expenses | 261.01 Million | 233.46 Million | 168.1 Million | 72.06 Million | 53.02 Million |
| Other Expenses | 2.58 Million | -8.08 Million | -14.03 Million | -9.44 Million | -6.61 Million |
| Cost and Expenses | 684.27 Million | 556.27 Million | 395.96 Million | 125.41 Million | 73.86 Million |
| Operating Income | -156.52 Million | -222.18 Million | -218.05 Million | -97.78 Million | -68.94 Million |
| Interest Expense | 1.25 Million | 722 Thousand | 307 Thousand | 666 Thousand | 1.03 Million |
| Income Tax Expense | - | 6.85 Million | -13.63 Million | -986 Thousand | -1.88 Million |
| Earnings before Tax | -78.73 Million | -113.55 Million | -199.68 Million | -100.46 Million | -66.64 Million |
| Net Income | -78.73 Million | -120.4 Million | -186.05 Million | -99.48 Million | -64.76 Million |
| Earnings Per Share Basic | -0.24 | -0.36 | -0.63 | -0.31 | -0.20 |
| Earnings Per Share Diluted | -0.24 | -0.36 | -0.63 | -0.31 | -0.20 |
| Weighted Average Shares Outstanding | 328.71 Million | 330.38 Million | 294.59 Million | 323.4 Million | 323.4 Million |
| Weighted Average Shares Outstanding (Diluted) | 328.71 Million | 330.38 Million | 294.59 Million | 323.4 Million | 323.4 Million |
| Gross Margin | 0.73 | 0.76 | 0.74 | 0.59 | 0.24 |
| EBIT Margin | -0.08 | -0.24 | -1.12 | -3.32 | -11.99 |
| Profit Margin | -0.15 | -0.36 | -1.05 | -3.60 | -13.17 |
| EBITDA | -41.6 Million | -86.56 Million | -199.94 Million | -90.16 Million | -58.96 Million |
| Earnings Before Tax Margin | -0.30 | -0.67 | -1.23 | -3.54 | -14.02 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 182.99 Million | 182.99 Million | 148.81 Million | 527.75 Million | 148.81 Million | 115.06 Million |
| Cost of Revenue | 52.53 Million | 52.53 Million | 41.64 Million | 142.76 Million | 41.64 Million | 29.74 Million |
| Gross Profit | 130.45 Million | 130.45 Million | 107.17 Million | 384.98 Million | 107.17 Million | 85.32 Million |
| Operating Expenses | 112.15 Million | 112.15 Million | 148.36 Million | 529.42 Million | 148.36 Million | 122.38 Million |
| Selling, General and Administrative Expenses | 61.78 Million | 61.78 Million | 76.31 Million | - | 76.31 Million | 62.64 Million |
| Research and Development Expenses | 50.77 Million | 50.77 Million | 65.1 Million | - | 65.1 Million | 65.4 Million |
| Other Expenses | -400.5 Thousand | -400.5 Thousand | 6.94 Million | -3.21 Million | - | - |
| Cost and Expenses | 164.69 Million | 164.69 Million | 190 Million | 672.18 Million | 190 Million | 152.13 Million |
| Operating Income | 18.29 Million | 18.29 Million | -41.19 Million | -156.52 Million | -32.51 Million | -41.06 Million |
| Interest Expense | - | - | - | 1.25 Million | - | 391.3 Thousand |
| Income Tax Expense | 3.83 Million | 3.83 Million | 145.5 Thousand | 88.16 Million | 145.5 Thousand | 145.5 Thousand |
| Earnings before Tax | 34.43 Million | 34.43 Million | -21.75 Million | -78.73 Million | -21.75 Million | -17.61 Million |
| Net Income | 34.43 Million | 34.43 Million | -21.61 Million | -78.73 Million | -21.61 Million | -17.75 Million |
| Earnings Per Share Basic | 0.11 | 0.11 | -0.07 | - | -0.07 | -0.05 |
| Earnings Per Share Diluted | 0.11 | 0.11 | -0.07 | - | -0.07 | -0.05 |
| Weighted Average Shares Outstanding | 327.61 Million | 327.61 Million | 327.74 Million | 328.71 Million | 327.74 Million | 329.68 Million |
| Weighted Average Shares Outstanding (Diluted) | 327.63 Million | 327.63 Million | 327.73 Million | 328.71 Million | 327.73 Million | 329.68 Million |
| Gross Margin | 0.71 | 0.71 | 0.72 | 0.73 | 0.72 | 0.74 |
| EBIT Margin | 0.16 | 0.16 | -0.16 | - | -0.16 | -0.30 |
| Profit Margin | 0.19 | 0.19 | -0.15 | -0.15 | -0.15 | -0.15 |
| EBITDA | 29.94 Million | 29.94 Million | -24.44 Million | - | -24.44 Million | -34.58 Million |
| Earnings Before Tax Margin | 0.10 | 0.10 | -0.28 | -0.30 | -0.22 | -0.36 |
6403
RBBN
FLCX
TIKK
HECOF
IFUS